Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
Adeola Adeyeye(National Institutes of Health), Zhe Wang(Zhongda Hospital Southeast University), Christina Psaros(Harvard University), Kailazarid Gomez Feliciano(Family Health International 360), Andrea Jennings(Family Health International 360), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Carolina Coutinho(Fundação Oswaldo Cruz), Bernardo Maia(Instituto de Infectologia Emílio Ribas), Steven A. Safren(University of Miami), Javier Valencia(Asociación Civil Impacta Salud y Educación), Keren Middelkoop(Desmond Tutu HIV Foundation), Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Julie Franks(Harlem United), Emília M. Jalil(Fundação Oswaldo Cruz), Jonathan Lucas(Family Health International 360), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Taimur Khan(Fenway Health), Philip A. Sullivan(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Mark A. Marzinke(Family Health International 360), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alex R. Rinehart, Yashna Singh(Desmond Tutu HIV Foundation), HPTN study group, Naiymah Sanchez(Family Health International 360), Nadir Cardozo(Fundación Huésped), Paul A. Richardson(Johns Hopkins University), Susan L. Ford(Research Triangle Park Foundation)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k